Phenotyping Diabetic Retinopathy
NCT00840541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2014-04-07
Summary
The purpose of this study is to validate and characterize phenotypes of diabetic retinopathy (DR) progression based on available clinical data (demographic, systemic and ophthalmic data).
Conditions
Sponsors & Collaborators
-
Association for Innovation and Biomedical Research on Light and Image
lead OTHER
Principal Investigators
-
José Cunha-Vaz, MD PhD · Association for Innovation and Biomedical Research on Light and Image
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2010-01-31
- Completion
- 2012-01-31
Countries
- Portugal
Study Locations
More Related Trials
-
Biomarkers of Diabetic Retinopathy Progression
NCT01607190 ·Status: COMPLETED
-
Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2
NCT00763802 ·Status: COMPLETED
-
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
NCT01320345 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Long Term Follow-Up of Diabetic Retinopathy
NCT00001395 ·Status: COMPLETED
-
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
NCT07270133 ·Status: NOT_YET_RECRUITING
-
Genetic Markers and Proliferative Diabetic Retinopathy
NCT02879422 ·Status: COMPLETED ·Phase: NA
-
Automated AI-based System for Early Diagnosis of Diabetic Retinopathy
NCT05324189 ·Status: UNKNOWN
-
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
NCT03437551 ·Status: COMPLETED
-
A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy
NCT02963441 ·Status: COMPLETED
-
The Diabetic Retinopathy Screening, Prevention and Control Program
NCT04240652 ·Status: RECRUITING
-
Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
NCT06582472 ·Status: RECRUITING
-
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
NCT02837640 ·Status: UNKNOWN ·Phase: PHASE2
-
Shanghai Beixinjing Diabetic Eyes Study
NCT03571217 ·Status: UNKNOWN
-
Oral Diclofenac for Retinal Photocoagulation in Diabetic Retinopathy
NCT01009021 ·Status: COMPLETED ·Phase: NA
-
Skin and Retina Microvascular Endothelial Function in Healthy, Insulin Resistant and Type 2 Diabetic Subjects
NCT01241370 ·Status: COMPLETED
-
Treating Early Stage Diabetic Retinopathy
NCT05132660 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Assessment of Color Vision in Diabetic Patients
NCT03345667 ·Status: COMPLETED
-
Study Investigating the Levels and Effects of Low-grade Inflammation in Diabetic Retinopathy of Type 1 Diabetes
NCT00880139 ·Status: TERMINATED
-
Fenofibrate for Prevention of DR Worsening
NCT04661358 ·Status: RECRUITING ·Phase: PHASE3
-
Lowering Events in Non-proliferative Retinopathy in Scotland
NCT03439345 ·Status: COMPLETED ·Phase: PHASE4
-
Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER)
NCT01440660 ·Status: COMPLETED
-
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
NCT01790945 ·Status: UNKNOWN
-
Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy
NCT02062034 ·Status: COMPLETED ·Phase: PHASE2
-
Management of Diabetes Mellitus Patients With Retinopathy
NCT00828425 ·Status: COMPLETED
-
Study of Natural Course Progression of Diabetic Retinopathy
NCT06269419 ·Status: RECRUITING